Vitamin D Supplementation in Functional Recovery of Subjects with Severe Acquired Brain Injury: A Pilot Controlled Randomized Study

• Published in: Neurotrauma reports Vol. 5; no. 1; pp. 66 - 616
• Main Authors: Intiso, Domenico, Centra, Antonello Marco, Gravina, Michele, Copetti, Massimiliano, Fontana, Andrea, Bartolo, Michelangelo, Filoni, Serena, Di Rienzo, Filomena
• Format: Journal Article
• Language: English
• Published: United States Mary Ann Liebert, Inc., publishers 01.07.2024; Mary Ann Liebert
• Subjects: acquired brain injury; outcome; Regular Manuscript; rehabilitation; vitamin D; vitamin D supplementation; rehabilitation; vitamin D supplementation; acquired brain injury; vitamin D; outcome
• ISSN: 2689-288X; 2689-288X
• DOI: 10.1089/neur.2023.0128

Low vitamin D (VD) has been associated with poor clinical course in several neurological diseases. Supplementation has been suggested to improve outcomes. Severe acquired brain injury (sABI) subjects have low VD levels and disabling conditions requiring rehabilitation. The aim of the present study was to evaluate if VD supplementation produced a better clinical course and a better functional outcome in sABI during rehabilitation. A randomized single-blind study was performed. sABI subjects were randomized to the VD supplementation group (VDsG) (initial dose of 50.000 UI and 1.000 daily) and usual care control group (CG). Disability Rating Scale (DRS), Glasgow Outcome Scale (GOS), and Level of Cognitive Functioning (LCF) were used in assessing disability. A total of 73 subjects (42 M and 31 F; mean age 53.2 ± 15.7) were randomized: 36 (21 M and 15 F; mean age 57.52 ± 14.88) to VDsG and 37 (20 M and 17 F; mean age 48.28 ± 17.47) to CG. Both groups significantly improved after rehabilitation, and no between-group difference was observed. The mean score values for DRS, GOS, and LCF in VDsG were 18.83 ± 4.27 and 9.42 ± 5.83; 2.89 ± 0.32 and 3.78 ± 0.80; and 4.81 ± 1.70 and 7.53 ± 1.28, at admission and discharge, respectively. Likewise, mean values for DRS, GOS, and LCF in CG were 18.57 ± 4.80 and 9.84 ± 6.34; 2.84 ± 0.37 and 3.81 ± 0.94; and 4.97 ± 2.01 and 7.41 ± 1.32, respectively. VD supplementation did not improve functional outcomes in sABI during rehabilitation treatment.